BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1095 related articles for article (PubMed ID: 33719081)

  • 21. Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis.
    Hariyanto TI; Hardyson W; Kurniawan A
    Drug Res (Stuttg); 2021 May; 71(5):265-274. PubMed ID: 33401328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.
    Vitiello A; Ferrara F
    Respir Med; 2021 Mar; 178():106322. PubMed ID: 33550151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of colchicine in the management of COVID-19: a Meta-analysis.
    Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF
    BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine, COVID-19 and hematological parameters: A meta-analysis.
    Sarwar M; Ali Z; Fatima M; Sarfraz Z; Sarfraz A; Cherrez-Ojeda I
    J Clin Lab Anal; 2021 Dec; 35(12):e24057. PubMed ID: 34708886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
    Manenti L; Maggiore U; Fiaccadori E; Meschi T; Antoni AD; Nouvenne A; Ticinesi A; Cerundolo N; Prati B; Delsante M; Gandoflini I; Donghi L; Gentile M; Farina MT; Oliva V; Zambrano C; Regolisti G; Palmisano A; Caminiti C; Cocchi E; Ferrari C; Riella LV; Cravedi P; Peruzzi L
    PLoS One; 2021; 16(3):e0248276. PubMed ID: 33760858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials.
    Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH
    High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):19-27. PubMed ID: 32860962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
    Rahman M; Datta PK; Islam K; Haque M; Mahmud R; Mallik U; Hasan P; Haque M; Faruq I; Sharif M; Ratul RH; Azad KAK; Miah T; Rahman MM
    PLoS One; 2022; 17(11):e0277790. PubMed ID: 36383611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Janus kinase inhibitors for the treatment of COVID-19.
    Kramer A; Prinz C; Fichtner F; Fischer AL; Thieme V; Grundeis F; Spagl M; Seeber C; Piechotta V; Metzendorf MI; Golinski M; Moerer O; Stephani C; Mikolajewska A; Kluge S; Stegemann M; Laudi S; Skoetz N
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015209. PubMed ID: 35695334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colchicine for Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chunfeng L; Ping L; Yun Z; Di L; Qi W
    Heart Surg Forum; 2021 Oct; 24(5):E863-E867. PubMed ID: 34623257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression.
    Hariyanto TI; Intan D; Hananto JE; Putri C; Kurniawan A
    Diabetes Res Clin Pract; 2021 Sep; 179():109031. PubMed ID: 34461139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    Kim MS; An MH; Kim WJ; Hwang TH
    PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Immunodeficiency Virus (HIV) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A Meta-Analysis and Meta-Regression.
    Hariyanto TI; Putri C; Frinka P; Louisa J; Lugito NPH; Kurniawan A
    AIDS Res Hum Retroviruses; 2021 Jan; ():. PubMed ID: 33499744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
    Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
    Hariyanto TI; Putri C; Hananto JE; Arisa J; Fransisca V Situmeang R; Kurniawan A
    J Psychiatr Res; 2021 Oct; 142():361-368. PubMed ID: 34425488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.